Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
162.79
+2.67 (1.67%)
At close: Mar 9, 2026, 4:00 PM EDT
165.00
+2.21 (1.36%)
After-hours: Mar 9, 2026, 5:15 PM EDT
Novartis AG Employees
Novartis AG had 75,267 employees as of December 31, 2025. The number of employees decreased by 616 or -0.81% compared to the previous year.
Employees
75,267
Change (1Y)
-616
Growth (1Y)
-0.81%
Revenue / Employee
$752,973
Profits / Employee
$185,792
Market Cap
306.94B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,267 | -616 | -0.81% |
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
| Dec 31, 2019 | 103,914 | -21,247 | -16.98% |
| Dec 31, 2018 | 125,161 | 3,564 | 2.93% |
| Dec 31, 2017 | 121,597 | 3,204 | 2.71% |
| Dec 31, 2016 | 118,393 | -307 | -0.26% |
| Dec 31, 2015 | 118,700 | -14,713 | -11.03% |
| Dec 31, 2014 | 133,413 | -2,283 | -1.68% |
| Dec 31, 2013 | 135,696 | 7,972 | 6.24% |
| Dec 31, 2012 | 127,724 | 4,038 | 3.26% |
| Dec 31, 2011 | 123,686 | 4,268 | 3.57% |
| Dec 31, 2010 | 119,418 | 19,584 | 19.62% |
| Dec 31, 2009 | 99,834 | 3,117 | 3.22% |
| Dec 31, 2008 | 96,717 | -1,483 | -1.51% |
| Dec 31, 2007 | 98,200 | -2,535 | -2.52% |
| Dec 31, 2006 | 100,735 | 9,735 | 10.70% |
| Dec 31, 2005 | 91,000 | 9,600 | 11.79% |
| Dec 31, 2004 | 81,400 | 2,859 | 3.64% |
| Dec 31, 2003 | 78,541 | 5,664 | 7.77% |
| Dec 31, 2002 | 72,877 | 2,557 | 3.64% |
| Dec 31, 2001 | 70,320 | 1,252 | 1.81% |
| Dec 31, 2000 | 69,068 | -13,391 | -16.24% |
| Dec 31, 1999 | 82,459 | -3,376 | -3.93% |
| Dec 31, 1998 | 85,835 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 68,629 |
| AbbVie | 57,000 |
NVS News
- 3 days ago - Novartis AG (NVS) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 3 days ago - Novartis (NVS) Shareholders Approve Key Resolutions at Annual Meeting - GuruFocus
- 3 days ago - Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting - GlobeNewsWire
- 4 days ago - Novartis AG (NVS) Shares Down 3.08% on Mar 5 - GuruFocus
- 5 days ago - Novartis And Henrietta Lacks' Family Reach A Settlement - Forbes
- 6 days ago - Novartis AG (NVS) Stock Price Down 3.43% on Mar 3 - GuruFocus
- 6 days ago - Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now - The Motley Fool
- 6 days ago - Commit fully to the role you’re in now, and your career may thank you later: Novartis CEO Vas Narasimhan - CNBC